~22 spots leftby Oct 2025

Legal Aid and Training for HIV Care

Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: University of Central Florida
Disqualifiers: Incarceration sentence, others
No Placebo Group

Trial Summary

What is the purpose of this trial?

This trial aims to improve HIV care for people who have been in prison by combining legal help with medical care. The program trains healthcare and legal staff to work together and provides integrated services to remove barriers to treatment.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It focuses on legal aid and training for HIV care, so it's best to ask the trial organizers for more details.

What data supports the effectiveness of the treatment Critical Time Legal Interventions for HIV care?

The systematic review on the organization of care for persons with HIV-infection found that case management and outreach interventions, which are components of Critical Time Legal Interventions, were associated with improved medical and economic outcomes, such as better antiretroviral prescribing and healthcare utilization.12345

How does the Legal Aid and Training for HIV Care treatment differ from other treatments for HIV?

This treatment is unique because it focuses on providing legal aid and training to empower people living with HIV, helping them manage stigma and discrimination, rather than directly addressing the medical aspects of HIV. It aims to create a supportive legal environment, which is an innovative approach compared to traditional medical treatments.678910

Research Team

Eligibility Criteria

This trial is for individuals who were previously incarcerated and are living with HIV/AIDS. It aims to explore how legal aid can improve their health outcomes. Participants should be interested in receiving legal assistance and willing to engage with healthcare providers trained in medical-legal partnerships.

Inclusion Criteria

I am 18 years old or older.
Living with HIV (as confirmed by medical record)
HIV viral load of more than 200 copies/mL (as confirmed by medical record)
See 3 more

Exclusion Criteria

Individuals who self-report having been sentenced to serve under state or federal custody, with a sentence to begin within 6 months from proposed enrollment in the study

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Training and Protocol Finalization

Engagement with advisory boards and finalization of protocols and training manual for the CTI-MLP approach

1 year

Implementation and Pilot Testing

Implementation of training and pilot testing of the CTI-MLP initiative with formerly incarcerated individuals living with HIV

6 months

Follow-up

Participants are monitored for HIV care continuum outcomes and quality of life improvements

1 year

Treatment Details

Interventions

  • Critical Time Legal Interventions (Behavioural Intervention)
Trial OverviewThe study tests the effect of providing legal aid on HIV care for those formerly incarcerated, alongside a training program for healthcare providers. The goal is to see if these interventions help patients stay on track with their HIV treatment and improve communication among caregivers.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: CTI-MLP assessmentExperimental Treatment1 Intervention
To assess the feasibility and acceptability of a comprehensive critical-time intervention medical legal partnership (CTI-MLP) approach to improve HIV care continuum outcomes among formerly incarcerated individuals and determine the most efficient mechanisms for CTI-MLP delivery
Group II: CTI-MLP approachExperimental Treatment1 Intervention
To finalize protocols and a medical-legal partnership training manual for health and social service providers at Hope and Help Inc.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Central Florida

Lead Sponsor

Trials
101
Recruited
1,191,000+

Dr. Michael Pape

University of Central Florida

Chief Executive Officer since 2015

PhD in Biochemistry from Purdue University, MBA from the University of Chicago Booth School of Business

Dr. James J. Hickman

University of Central Florida

Chief Medical Officer since 2020

MD from University of Central Florida College of Medicine

Hope and Help Center of Central Florida Incorporated

Collaborator

Trials
1
Recruited
100+

University of Miami

Collaborator

Trials
976
Recruited
423,000+
Sylvia Daunert profile image

Sylvia Daunert

University of Miami

Chief Executive Officer since 2011

PhD in Biochemistry and Molecular Biology, University of Kentucky

Bahar Motlagh profile image

Bahar Motlagh

University of Miami

Chief Medical Officer since 2021

PhD in Biomedical Engineering, Ecole Polytechnique Montreal

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+

Dr. Joshua A. Gordon

National Institute of Mental Health (NIMH)

Chief Executive Officer since 2016

MD, PhD

Dr. Shelli Avenevoli profile image

Dr. Shelli Avenevoli

National Institute of Mental Health (NIMH)

Chief Medical Officer

PhD

Findings from Research

Case management interventions were most consistently linked to improvements in immunological outcomes for people living with HIV/AIDS, although they did not show clear benefits for other health measures.
Outreach interventions demonstrated significant improvements in mortality rates, access to antiretroviral medications, and overall healthcare utilization, suggesting they are effective strategies for enhancing care for HIV/AIDS patients.
Organization of care for persons with HIV-infection: a systematic review.Handford, CD., Tynan, AM., Agha, A., et al.[2019]
A review of 32 articles highlighted that the knowledge of clinic staff about HIV significantly influences patient satisfaction, emphasizing the importance of well-informed healthcare providers.
While three instruments for measuring patient satisfaction in HIV care were identified, no gold standard exists, indicating a need for a valid and user-friendly tool to enhance service quality based on patient feedback.
Patient-derived outcome measures for HIV services in the developed world: a systematic review.Land, L., Nixon, S., Ross, JD.[2019]
A study of 6,847 HIV-infected individuals showed that early mortality rates significantly decreased from 8.8 deaths per 100 person-years in 2006 to 2.5 in 2016, largely due to improved patient care and earlier ART initiation at higher CD4 counts.
Improved patient care practices accounted for 46% of the reduction in early mortality, highlighting the importance of not only starting ART earlier but also enhancing the overall quality of care for patients.
Temporal trends of early mortality and its risk factors in HIV-infected adults initiating antiretroviral therapy in Uganda.Ssempijja, V., Namulema, E., Ankunda, R., et al.[2022]

References

Organization of care for persons with HIV-infection: a systematic review. [2019]
Patient-derived outcome measures for HIV services in the developed world: a systematic review. [2019]
Temporal trends of early mortality and its risk factors in HIV-infected adults initiating antiretroviral therapy in Uganda. [2022]
Study looks at care model to improve drug adherence. Retention care counselor is major feature. [2007]
The Treatment Advocacy Program--Sinai: a peer-based HIV prevention intervention for working with African American HIV-infected persons. [2022]
Sword and Shield: Perceptions of law in empowering and protecting HIV-positive men who have sex with men in Manila, Philippines. [2022]
Assessing changes in HIV-related legal and policy environments: Lessons learned from a multi-country evaluation. [2018]
HIV-related Legal Needs, Demographic Change, and Trends in Australia since 1992: A Review of Legal Administrative Data. [2023]
Developing guidance for HIV prosecutions: an example of harm reduction? [2016]
International law, human rights and HIV/AIDS. [2014]